Sponsorluk
11 neoantigen identification strategies redefining 2026 precision medicine
In 2026, the "holy grail" of oncology—identifying the exact genetic markers that distinguish a tumor from healthy tissue—has moved into the mainstream of clinical practice. New bioinformatics pipelines are now capable of analyzing a patient's entire exome and identifying the most "immunogenic" neoantigens in less than 48 hours. This technological leap is allowing for the rapid...
0 Yorumlar 0 hisse senetleri 430 Gösterim 0 Yorumlar
Sponsorluk
Sponsorluk
Sponsorluk